BioSpace News Archive

First Chemotherapy-Free, Anti-CD20 Combination Regimen Approved for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) in Previously Untreated Patients

Phase 3 iLLUMINATE study’s safety and efficacy results have the potential to add to data supporting IMBRUVICA as an effective treatment for CLL/SLL, alone and in combination with other therapies

Global Blood Therapeutics today reported recent business progress and financial results for the first quarter ended March 31, 2019.

H.C. Wainwright Global Life Sciences Conference in London on Tuesday, April 9, 2019, at 10:10 a.m. British Summer Time.

Cowen and Company 39th Annual Health Care Conference in Boston on Monday, March 11, 2019, at 4:50 p.m. Eastern Time.

8th Annual SVB Leerink Global Healthcare Conference in New York on Thursday, February 28, 2019, at 1 p.m. Eastern Time.

The Access to Excellent Care for Sickle Cell Patients Pilot Program (ACCEL) Supports Novel Projects Aimed at Improving Access to High-Quality Healthcare for People with Sickle Cell Disease

The 2019 ASCO Annual Meeting in Chicago is expected to bring together more than 32,000 oncology professionals from around the globe.

Morgan Stanley today announced the launch of Morgan Stanley GIFT Cures℠ powered by Harrington Discovery Institute, the first special interest program of The Morgan Stanley Global Impact Funding Trust (Morgan Stanley GIFT) that is dedicated to advancing the development of research discoveries into new cures and treatments for a broad range of diseases.

The Biotechnology Innovation Organization released “Transforming Ideas into Advances: Best Practices in State and Regional Bioscience Economic Development Initiatives” at the 2019 BIO International Convention.